AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar ramirogon (< 20) Submitted: 5/3/2011 7:23:43 PM : Outperform Start Price: $4.18 AVNR Score: -29.43

avnr

Featured Broker Partners


Advertisement